Literature DB >> 28844880

The FGF21-CCL11 Axis Mediates Beiging of White Adipose Tissues by Coupling Sympathetic Nervous System to Type 2 Immunity.

Zhe Huang1, Ling Zhong1, Jimmy Tsz Hang Lee1, Jialiang Zhang1, Donghai Wu2, Leiluo Geng1, Yu Wang3, Chi-Ming Wong4, Aimin Xu5.   

Abstract

Type 2 cytokines are important signals triggering biogenesis of thermogenic beige adipocytes in white adipose tissue (WAT) during cold acclimation. However, how cold activates type 2 immunity in WAT remains obscure. Here we show that cold-induced type 2 immune responses and beiging in subcutaneous WAT (scWAT) are abrogated in mice with adipose-selective ablation of FGF21 or its co-receptor β-Klotho, whereas such impairments are reversed by replenishment with chemokine CCL11. Mechanistically, FGF21 acts on adipocytes in an autocrine manner to promote the expression and secretion of CCL11 via activation of ERK1/2, which drives recruitment of eosinophils into scWAT, leading to increases in accumulation of M2 macrophages, and proliferation and commitment of adipocyte precursors into beige adipocytes. These FGF21-elicited type 2 immune responses and beiging are blocked by CCL11 neutralization. Thus, the adipose-derived FGF21-CCL11 axis triggers cold-induced beiging and thermogenesis by coupling sympathetic nervous system to activation of type 2 immunity in scWAT.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  adaptive thermogenesis; adipocyte precursor cells; adipose remodeling; beiging; eosinophils; eotaxin; macrophages; type 2 immunity

Mesh:

Substances:

Year:  2017        PMID: 28844880     DOI: 10.1016/j.cmet.2017.08.003

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  51 in total

Review 1.  Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication.

Authors:  Jan-Bernd Funcke; Philipp E Scherer
Journal:  J Lipid Res       Date:  2019-06-17       Impact factor: 5.922

2.  SGLT2 inhibition reprograms systemic metabolism via FGF21-dependent and -independent mechanisms.

Authors:  Soravis Osataphan; Chiara Macchi; Garima Singhal; Jeremy Chimene-Weiss; Vicencia Sales; Chisayo Kozuka; Jonathan M Dreyfuss; Hui Pan; Yanin Tangcharoenpaisan; Jordan Morningstar; Robert Gerszten; Mary-Elizabeth Patti
Journal:  JCI Insight       Date:  2019-03-07

Review 3.  Innate immune cells in the adipose tissue.

Authors:  Kyoung-Jin Chung; Marina Nati; Triantafyllos Chavakis; Antonios Chatzigeorgiou
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

Review 4.  Adaptive thermogenesis by dietary n-3 polyunsaturated fatty acids: Emerging evidence and mechanisms.

Authors:  Rong Fan; Karsten Koehler; Soonkyu Chung
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-04-19       Impact factor: 4.698

Review 5.  Growth Factors as Immunotherapeutic Targets in Cardiovascular Disease.

Authors:  John E Mindur; Filip K Swirski
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-05-16       Impact factor: 8.311

Review 6.  Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis.

Authors:  Lucas D BonDurant; Matthew J Potthoff
Journal:  Annu Rev Nutr       Date:  2018-05-04       Impact factor: 11.848

Review 7.  Fighting obesity by targeting factors regulating beige adipocytes.

Authors:  Allison E McQueen; Suneil K Koliwad; Jen-Chywan Wang
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2018-11       Impact factor: 4.294

Review 8.  The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic.

Authors:  Leiluo Geng; Karen S L Lam; Aimin Xu
Journal:  Nat Rev Endocrinol       Date:  2020-08-06       Impact factor: 43.330

Review 9.  Contributions of innate type 2 inflammation to adipose function.

Authors:  W Reid Bolus; Alyssa H Hasty
Journal:  J Lipid Res       Date:  2018-06-11       Impact factor: 5.922

10.  Perilipin-2 deletion promotes carbohydrate-mediated browning of white adipose tissue at ambient temperature.

Authors:  Andrew E Libby; Elise S Bales; Jenifer Monks; David J Orlicky; James L McManaman
Journal:  J Lipid Res       Date:  2018-06-04       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.